Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,372 | 52 | 81.5% |
| Education | $311.04 | 4 | 18.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $394.82 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $169.08 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $135.27 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $121.66 | 2 | $0 (2024) |
| PharmaEssentia USA Corporation | $99.93 | 3 | $0 (2024) |
| GENZYME CORPORATION | $98.05 | 5 | $0 (2024) |
| Incyte Corporation | $95.00 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $82.38 | 4 | $0 (2024) |
| SOBI, INC | $77.81 | 3 | $0 (2024) |
| Celgene Corporation | $57.32 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,193 | 45 | AstraZeneca Pharmaceuticals LP ($154.44) |
| 2023 | $489.23 | 11 | Janssen Biotech, Inc. ($242.93) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Oncology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| 12/10/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $33.27 | General |
| Category: VTE | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $30.74 | General |
| Category: Oncology | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $14.80 | General |
| 11/18/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Oncology | ||||||
| 11/01/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Oncology | ||||||
| 09/13/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $21.24 | General |
| Category: Oncology | ||||||
| 09/12/2024 | GENZYME CORPORATION | ENJAYMO (Biological), CABLIVI | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: Hematology | ||||||
| 08/28/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $20.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/08/2024 | GENZYME CORPORATION | CABLIVI (Biological), ENJAYMO | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Hematology | ||||||
| 07/01/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $34.58 | General |
| Category: Oncology | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $123.70 | General |
| Category: Oncology | ||||||
| 06/11/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.46 | General |
| Category: Oncology | ||||||
| 06/03/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/03/2024 | Genentech USA, Inc. | Alecensa (Biological), Rozlytrek, Tecentriq | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: BioOncology | ||||||
| 05/29/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Oncology | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Oncology | ||||||
| 05/13/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 58 | 59 | $17,090 | $3,794 |
| 2022 | 1 | 16 | 38 | $12,768 | $2,530 |
| 2021 | 2 | 40 | 72 | $21,540 | $4,444 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 47 | $11,750 | $2,751 | 23.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $5,340 | $1,043 | 19.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 38 | $12,768 | $2,530 | 19.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 46 | $15,456 | $3,270 | 21.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 26 | $6,084 | $1,174 | 19.3% |
About Ronald Brown, PA-C
Ronald Brown, PA-C is a Medical healthcare provider based in Gunter, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/11/2019. The National Provider Identifier (NPI) number assigned to this provider is 1477191237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ronald Brown, PA-C has received a total of $1,683 in payments from pharmaceutical and medical device companies, with $1,193 received in 2024. These payments were reported across 56 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,372).
As a Medicare-enrolled provider, Brown has provided services to 114 Medicare beneficiaries, totaling 169 services with total Medicare billing of $10,768. Data is available for 3 years (2021–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Gunter, TX
- Active Since 12/11/2019
- Last Updated 12/11/2019
- Taxonomy Code 363AM0700X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477191237
Products in Payments
- DARZALEX (Biological) $353.54
- ENHERTU (Biological) $123.70
- KISQALI (Drug) $112.25
- BESREMI (Drug) $99.93
- OPDIVO (Biological) $63.50
- REBLOZYL (Biological) $57.32
- Doptelet (Drug) $53.79
- CABLIVI (Biological) $53.35
- OJJAARA (Drug) $44.23
- FLOWTRIEVER CATHETER, S (Device) $33.27
- IMFINZI (Biological) $30.74
- ENJAYMO (Biological) $29.90
- Vanflyta (Drug) $28.29
- Lenvima (Drug) $24.83
- clonoSEQ (Device) $24.71
- DOPTELET (Drug) $24.02
- CARVYKTI (Drug) $23.31
- PIQRAY (Drug) $23.02
- Alecensa (Biological) $22.79
- Padcev (Drug) $21.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.